fintopic.
Docs Get the API

Seawolf Therapeutics raises $100 million to advance DNA-based therapeutics

3 statements from 3 sources on Nov 16, 2026, 10:00–10:00 UTC
Part of Deals & M&A
News
Updated
Front page

Statements (3)

  1. Neutral

    Seawolf Therapeutics launched a new company with $100 million to fund non-viral gene therapies

    endpoints.news
  2. Bullish

    Big-name investors poured $100 million into DNA therapeutics developer Seawolf

    biopharmadive.comHigh importance
  3. Neutral

    Seawolf Therapeutics raised $100 million to advance DNA-based therapeutics

    businesswire.com